The risk of cardiovascular events in metabolic dysfunction-associated steatotic liver disease according to fibrosis stage and diabetes status: A cohort study.

Baseline 10-year atherosclerotic cardiovascular disease risk increased with worsening glycemic status.

In the longitudinal analysis, the association between fibrosis severity and incident atherosclerotic cardiovascular disease differed by glycemic status.

This association was also more apparent in younger individuals.

In patients with diabetes, 5-year cumulative atherosclerotic cardiovascular disease incidence was high across fibrosis tiers (15.2%-18.5%), without a significant increase by fibrosis severity.